Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Evaluate Efficacy of Iocide Oral Rinse in a Human Clinical Trial of Gingival Inflammation and Investigate Effects on Biological Markers Indicative of Systemic Disease

NCT01782170 is registered in ClinicalTrials.gov with Biomedical Development Corporation as lead sponsor.

NCT NCT01782170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01782170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Evaluate Efficacy of Iocide Oral Rinse in a Human Clinical Trial of Gingival Inflammation and Investigate Effects on Biological Markers Indicative of Systemic Disease
Lead sponsor
Biomedical Development Corporation
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2013
Completion date
May 31, 2014
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gingivitis, investigation of biological markers of inflammation